1.
Ghetti G, Spiombi E, Amoroso L, Viti R, Spada M. Cost Evaluation and Economic Sustainability of Enzyme Replacement Therapies for Fabry Disease in Italy from the Hospital Perspective. FE [Internet]. 2025 Oct. 23 [cited 2026 Jun. 25];26(1). Available from: https://journals.seedstm.com/index.php/FE/article/view/1582